世界のパジェット病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Paget's Disease Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4647 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、パジェット病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ビスフォスフォネート、カルシトニン類似体（サーモンカルシトニン）、鎮痛剤、カルシウム・ビタミンDサプリメント）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・パジェット病治療の市場動向 ・企業の競争状況、市場シェア ・パジェット病治療の種類別市場規模と予測2016-2027（ビスフォスフォネート、カルシトニン類似体（サーモンカルシトニン）、鎮痛剤、カルシウム・ビタミンDサプリメント） ・パジェット病治療の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・パジェット病治療の北米市場規模2016-2027（アメリカ、カナダ） ・パジェット病治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・パジェット病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・パジェット病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・パジェット病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis AG、Mylan NV、Teva Pharmaceutical Industries Ltd.、Neopharma, Inc.、Sanofi S.A.、Allergan(AbbVie)、Fresenius Kabi、Sun Pharmaceutical Industries, Ltd.、Mallinckrodt Pharmaceuticals） ・結論

Paget’s disease is a chronic condition which interferes with your body’s normal bone remodeling process. … Over time, the disease can cause affected bones to become fragile and misshapen. Paget’s disease of bone most commonly occurs in the pelvis, skull, spine and legs.

Market Analysis and Insights: Global Paget’s Disease Treatment Market
The global Paget’s Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Paget’s Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Paget’s Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Paget’s Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Paget’s Disease Treatment market.

Global Paget’s Disease Treatment Scope and Market Size
Paget’s Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Paget’s Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Bisphosphonates
Calcitonin Analogues (Salmon Calcitonin)
Analgesics
Calcium and Vitamin D Supplements

Segment by Application
Hospitals
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis AG
Mylan NV
Teva Pharmaceutical Industries Ltd.
Neopharma, Inc.
Sanofi S.A.
Allergan(AbbVie)
Fresenius Kabi
Sun Pharmaceutical Industries, Ltd.
Mallinckrodt Pharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Paget’s Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bisphosphonates
1.2.3 Calcitonin Analogues (Salmon Calcitonin)
1.2.4 Analgesics
1.2.5 Calcium and Vitamin D Supplements
1.3 Market by Application
1.3.1 Global Paget’s Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Paget’s Disease Treatment Market Perspective (2016-2027)
2.2 Paget’s Disease Treatment Growth Trends by Regions
2.2.1 Paget’s Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Paget’s Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Paget’s Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Paget’s Disease Treatment Industry Dynamic
2.3.1 Paget’s Disease Treatment Market Trends
2.3.2 Paget’s Disease Treatment Market Drivers
2.3.3 Paget’s Disease Treatment Market Challenges
2.3.4 Paget’s Disease Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Paget’s Disease Treatment Players by Revenue
3.1.1 Global Top Paget’s Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Paget’s Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Paget’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Paget’s Disease Treatment Revenue
3.4 Global Paget’s Disease Treatment Market Concentration Ratio
3.4.1 Global Paget’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Paget’s Disease Treatment Revenue in 2020
3.5 Paget’s Disease Treatment Key Players Head office and Area Served
3.6 Key Players Paget’s Disease Treatment Product Solution and Service
3.7 Date of Enter into Paget’s Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Paget’s Disease Treatment Breakdown Data by Type
4.1 Global Paget’s Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Paget’s Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Paget’s Disease Treatment Breakdown Data by Application
5.1 Global Paget’s Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Paget’s Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Paget’s Disease Treatment Market Size (2016-2027)
6.2 North America Paget’s Disease Treatment Market Size by Type
6.2.1 North America Paget’s Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Paget’s Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Paget’s Disease Treatment Market Size by Type (2016-2027)
6.3 North America Paget’s Disease Treatment Market Size by Application
6.3.1 North America Paget’s Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Paget’s Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Paget’s Disease Treatment Market Size by Application (2016-2027)
6.4 North America Paget’s Disease Treatment Market Size by Country
6.4.1 North America Paget’s Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Paget’s Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Paget’s Disease Treatment Market Size (2016-2027)
7.2 Europe Paget’s Disease Treatment Market Size by Type
7.2.1 Europe Paget’s Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Paget’s Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Paget’s Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Paget’s Disease Treatment Market Size by Application
7.3.1 Europe Paget’s Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Paget’s Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Paget’s Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Paget’s Disease Treatment Market Size by Country
7.4.1 Europe Paget’s Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Paget’s Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Paget’s Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Paget’s Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Paget’s Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Paget’s Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Paget’s Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Paget’s Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Paget’s Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Paget’s Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Paget’s Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Paget’s Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Paget’s Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Paget’s Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Paget’s Disease Treatment Market Size (2016-2027)
9.2 Latin America Paget’s Disease Treatment Market Size by Type
9.2.1 Latin America Paget’s Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Paget’s Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Paget’s Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Paget’s Disease Treatment Market Size by Application
9.3.1 Latin America Paget’s Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Paget’s Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Paget’s Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Paget’s Disease Treatment Market Size by Country
9.4.1 Latin America Paget’s Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Paget’s Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Paget’s Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Paget’s Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Paget’s Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Paget’s Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Paget’s Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Paget’s Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Paget’s Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Paget’s Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Paget’s Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Paget’s Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Paget’s Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Paget’s Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Paget’s Disease Treatment Introduction
11.1.4 Novartis AG Revenue in Paget’s Disease Treatment Business (2016-2021)
11.1.5 Novartis AG Recent Development
11.2 Mylan NV
11.2.1 Mylan NV Company Details
11.2.2 Mylan NV Business Overview
11.2.3 Mylan NV Paget’s Disease Treatment Introduction
11.2.4 Mylan NV Revenue in Paget’s Disease Treatment Business (2016-2021)
11.2.5 Mylan NV Recent Development
11.3 Teva Pharmaceutical Industries Ltd.
11.3.1 Teva Pharmaceutical Industries Ltd. Company Details
11.3.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.3.3 Teva Pharmaceutical Industries Ltd. Paget’s Disease Treatment Introduction
11.3.4 Teva Pharmaceutical Industries Ltd. Revenue in Paget’s Disease Treatment Business (2016-2021)
11.3.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.4 Neopharma, Inc.
11.4.1 Neopharma, Inc. Company Details
11.4.2 Neopharma, Inc. Business Overview
11.4.3 Neopharma, Inc. Paget’s Disease Treatment Introduction
11.4.4 Neopharma, Inc. Revenue in Paget’s Disease Treatment Business (2016-2021)
11.4.5 Neopharma, Inc. Recent Development
11.5 Sanofi S.A.
11.5.1 Sanofi S.A. Company Details
11.5.2 Sanofi S.A. Business Overview
11.5.3 Sanofi S.A. Paget’s Disease Treatment Introduction
11.5.4 Sanofi S.A. Revenue in Paget’s Disease Treatment Business (2016-2021)
11.5.5 Sanofi S.A. Recent Development
11.6 Allergan(AbbVie)
11.6.1 Allergan(AbbVie) Company Details
11.6.2 Allergan(AbbVie) Business Overview
11.6.3 Allergan(AbbVie) Paget’s Disease Treatment Introduction
11.6.4 Allergan(AbbVie) Revenue in Paget’s Disease Treatment Business (2016-2021)
11.6.5 Allergan(AbbVie) Recent Development
11.7 Fresenius Kabi
11.7.1 Fresenius Kabi Company Details
11.7.2 Fresenius Kabi Business Overview
11.7.3 Fresenius Kabi Paget’s Disease Treatment Introduction
11.7.4 Fresenius Kabi Revenue in Paget’s Disease Treatment Business (2016-2021)
11.7.5 Fresenius Kabi Recent Development
11.8 Sun Pharmaceutical Industries, Ltd.
11.8.1 Sun Pharmaceutical Industries, Ltd. Company Details
11.8.2 Sun Pharmaceutical Industries, Ltd. Business Overview
11.8.3 Sun Pharmaceutical Industries, Ltd. Paget’s Disease Treatment Introduction
11.8.4 Sun Pharmaceutical Industries, Ltd. Revenue in Paget’s Disease Treatment Business (2016-2021)
11.8.5 Sun Pharmaceutical Industries, Ltd. Recent Development
11.9 Mallinckrodt Pharmaceuticals
11.9.1 Mallinckrodt Pharmaceuticals Company Details
11.9.2 Mallinckrodt Pharmaceuticals Business Overview
11.9.3 Mallinckrodt Pharmaceuticals Paget’s Disease Treatment Introduction
11.9.4 Mallinckrodt Pharmaceuticals Revenue in Paget’s Disease Treatment Business (2016-2021)
11.9.5 Mallinckrodt Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Paget's Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bisphosphonates
Table 3. Key Players of Calcitonin Analogues (Salmon Calcitonin)
Table 4. Key Players of Analgesics
Table 5. Key Players of Calcium and Vitamin D Supplements
Table 6. Global Paget's Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Paget's Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Paget's Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Paget's Disease Treatment Market Share by Regions (2016-2021)
Table 10. Global Paget's Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Paget's Disease Treatment Market Share by Regions (2022-2027)
Table 12. Paget's Disease Treatment Market Trends
Table 13. Paget's Disease Treatment Market Drivers
Table 14. Paget's Disease Treatment Market Challenges
Table 15. Paget's Disease Treatment Market Restraints
Table 16. Global Paget's Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Paget's Disease Treatment Market Share by Players (2016-2021)
Table 18. Global Top Paget's Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paget's Disease Treatment as of 2020)
Table 19. Ranking of Global Top Paget's Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Paget's Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Paget's Disease Treatment Product Solution and Service
Table 23. Date of Enter into Paget's Disease Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Paget's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Paget's Disease Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Paget's Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Paget's Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Paget's Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Paget's Disease Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Paget's Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Paget's Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Paget's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Paget's Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Paget's Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Paget's Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Paget's Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Paget's Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Paget's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Paget's Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Paget's Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Paget's Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Paget's Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Paget's Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Paget's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Paget's Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Paget's Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Paget's Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Paget's Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Paget's Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Paget's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Paget's Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Paget's Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Paget's Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Paget's Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Paget's Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Paget's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Paget's Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Paget's Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Paget's Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Paget's Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Paget's Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Novartis AG Company Details
Table 64. Novartis AG Business Overview
Table 65. Novartis AG Paget's Disease Treatment Product
Table 66. Novartis AG Revenue in Paget's Disease Treatment Business (2016-2021) & (US$ Million)
Table 67. Novartis AG Recent Development
Table 68. Mylan NV Company Details
Table 69. Mylan NV Business Overview
Table 70. Mylan NV Paget's Disease Treatment Product
Table 71. Mylan NV Revenue in Paget's Disease Treatment Business (2016-2021) & (US$ Million)
Table 72. Mylan NV Recent Development
Table 73. Teva Pharmaceutical Industries Ltd. Company Details
Table 74. Teva Pharmaceutical Industries Ltd. Business Overview
Table 75. Teva Pharmaceutical Industries Ltd. Paget's Disease Treatment Product
Table 76. Teva Pharmaceutical Industries Ltd. Revenue in Paget's Disease Treatment Business (2016-2021) & (US$ Million)
Table 77. Teva Pharmaceutical Industries Ltd. Recent Development
Table 78. Neopharma, Inc. Company Details
Table 79. Neopharma, Inc. Business Overview
Table 80. Neopharma, Inc. Paget's Disease Treatment Product
Table 81. Neopharma, Inc. Revenue in Paget's Disease Treatment Business (2016-2021) & (US$ Million)
Table 82. Neopharma, Inc. Recent Development
Table 83. Sanofi S.A. Company Details
Table 84. Sanofi S.A. Business Overview
Table 85. Sanofi S.A. Paget's Disease Treatment Product
Table 86. Sanofi S.A. Revenue in Paget's Disease Treatment Business (2016-2021) & (US$ Million)
Table 87. Sanofi S.A. Recent Development
Table 88. Allergan(AbbVie) Company Details
Table 89. Allergan(AbbVie) Business Overview
Table 90. Allergan(AbbVie) Paget's Disease Treatment Product
Table 91. Allergan(AbbVie) Revenue in Paget's Disease Treatment Business (2016-2021) & (US$ Million)
Table 92. Allergan(AbbVie) Recent Development
Table 93. Fresenius Kabi Company Details
Table 94. Fresenius Kabi Business Overview
Table 95. Fresenius Kabi Paget's Disease Treatment Product
Table 96. Fresenius Kabi Revenue in Paget's Disease Treatment Business (2016-2021) & (US$ Million)
Table 97. Fresenius Kabi Recent Development
Table 98. Sun Pharmaceutical Industries, Ltd. Company Details
Table 99. Sun Pharmaceutical Industries, Ltd. Business Overview
Table 100. Sun Pharmaceutical Industries, Ltd. Revenue in Paget's Disease Treatment Business (2016-2021) & (US$ Million)
Table 101. Sun Pharmaceutical Industries, Ltd. Recent Development
Table 102. Mallinckrodt Pharmaceuticals Company Details
Table 103. Mallinckrodt Pharmaceuticals Business Overview
Table 104. Mallinckrodt Pharmaceuticals Paget's Disease Treatment Product
Table 105. Mallinckrodt Pharmaceuticals Revenue in Paget's Disease Treatment Business (2016-2021) & (US$ Million)
Table 106. Mallinckrodt Pharmaceuticals Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Paget's Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Bisphosphonates Features
Figure 3. Calcitonin Analogues (Salmon Calcitonin) Features
Figure 4. Analgesics Features
Figure 5. Calcium and Vitamin D Supplements Features
Figure 6. Global Paget's Disease Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Paget's Disease Treatment Report Years Considered
Figure 11. Global Paget's Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Paget's Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Paget's Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Paget's Disease Treatment Market Share by Regions (2022-2027)
Figure 15. Global Paget's Disease Treatment Market Share by Players in 2020
Figure 16. Global Top Paget's Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paget's Disease Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Paget's Disease Treatment Revenue in 2020
Figure 18. Global Paget's Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Paget's Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Paget's Disease Treatment Market Share by Type (2016-2027)
Figure 22. North America Paget's Disease Treatment Market Share by Application (2016-2027)
Figure 23. North America Paget's Disease Treatment Market Share by Country (2016-2027)
Figure 24. United States Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Paget's Disease Treatment Market Share by Type (2016-2027)
Figure 28. Europe Paget's Disease Treatment Market Share by Application (2016-2027)
Figure 29. Europe Paget's Disease Treatment Market Share by Country (2016-2027)
Figure 30. Germany Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Paget's Disease Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Paget's Disease Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Paget's Disease Treatment Market Share by Region (2016-2027)
Figure 40. China Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Paget's Disease Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Paget's Disease Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Paget's Disease Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Paget's Disease Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Paget's Disease Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Paget's Disease Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Paget's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Novartis AG Revenue Growth Rate in Paget's Disease Treatment Business (2016-2021)
Figure 60. Mylan NV Revenue Growth Rate in Paget's Disease Treatment Business (2016-2021)
Figure 61. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Paget's Disease Treatment Business (2016-2021)
Figure 62. Neopharma, Inc. Revenue Growth Rate in Paget's Disease Treatment Business (2016-2021)
Figure 63. Sanofi S.A. Revenue Growth Rate in Paget's Disease Treatment Business (2016-2021)
Figure 64. Allergan(AbbVie) Revenue Growth Rate in Paget's Disease Treatment Business (2016-2021)
Figure 65. Fresenius Kabi Revenue Growth Rate in Paget's Disease Treatment Business (2016-2021)
Figure 66. Sun Pharmaceutical Industries, Ltd. Revenue Growth Rate in Paget's Disease Treatment Business (2016-2021)
Figure 67. Mallinckrodt Pharmaceuticals Revenue Growth Rate in Paget's Disease Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---